Evidence-based dry-eye therapies for clinical use

8 October 2021
Volume 22, Issue 3

This article outlines a range of dry-eye disease management strategies available at each severity level and between subtypes of the disease.

Domains covered

Contact Lenses Ocular Disease Ocular Examination Information Options Safe

Despite recent advances in the management and treatment of dry-eye disease, the condition is still managed differently across continents and countries. From diagnosis to disease progression and treatment, patients should be well informed about the safe and effective use of available therapies. Consequently, this article aims to appraise eye care practitioners of a wide range of management strategies available at each severity level and between subtypes of dry-eye disease.

Sign in to continue

Forgotten password?
Register

Sign in to view the article

Not a member? Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.

Related further reading

Visual impairment is common after a stroke, but optometrists can help patients rehabilitate optically and by recommending effective online therapies, writes John Windell.

Heart attacks transiently increase in number when the clocks go forward. Diabetic retinopathy and glaucoma can interfere with the body’s sleep-wake cycles. Becky McCall examines the relationship between the eye and sleep.

Adrian O’Dowd asks how optometrists should respond to a rise in the rate of retinoblastoma in children across Europe.